These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17623343)

  • 1. Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints.
    Masch EJ; Albert JM
    Biom J; 2007 Jun; 49(3):378-93. PubMed ID: 17623343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating treatment efficacy over time: a logistic regression model for binary longitudinal outcomes.
    Choi L; Dominici F; Zeger SL; Ouyang P
    Stat Med; 2005 Sep; 24(18):2789-805. PubMed ID: 16134133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.
    Sullivan LM; D'Agostino RB
    Stat Med; 2003 Apr; 22(8):1317-34. PubMed ID: 12687657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exact and approximate unconditional confidence intervals for proportion difference in the presence of incomplete data.
    Tang ML; Ling MH; Tian GL
    Stat Med; 2009 Feb; 28(4):625-41. PubMed ID: 19035467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size for testing difference between two proportions for the bilateral-sample design.
    Qiu SF; Tang NS; Tang ML; Pei YB
    J Biopharm Stat; 2009 Sep; 19(5):857-71. PubMed ID: 20183448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simulation study of odds ratio estimation for binary outcomes from cluster randomized trials.
    Ukoumunne OC; Carlin JB; Gulliford MC
    Stat Med; 2007 Aug; 26(18):3415-28. PubMed ID: 17154246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing homogeneity of two zero-inflated Poisson populations.
    Tse SK; Chow SC; Lu Q; Cosmatos D
    Biom J; 2009 Feb; 51(1):159-70. PubMed ID: 19219907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of the rank sum test for clustered data: two-group comparisons with group membership defined at the subunit level.
    Rosner B; Glynn RJ; Lee ML
    Biometrics; 2006 Dec; 62(4):1251-9. PubMed ID: 17156300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the effect of treatment in experiments with correlated binary outcomes.
    Zucker D; Wittes J
    Biometrics; 1992 Sep; 48(3):695-709. PubMed ID: 1420835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating subject-treatment interaction when comparing two treatments.
    Gadbury GL; Iyer HK; Allison DB
    J Biopharm Stat; 2001 Nov; 11(4):313-33. PubMed ID: 12018782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    Am J Gastroenterol; 2009 Mar; 104(3):546-51. PubMed ID: 19262513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome.
    Cheng J
    Biometrics; 2009 Mar; 65(1):96-103. PubMed ID: 18373714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power and sample size calculations for discrete bounded outcome scores.
    Tsonaka R; Rizopoulos D; Lesaffre E
    Stat Med; 2006 Dec; 25(24):4241-52. PubMed ID: 16947202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stratified analysis in randomized trials with noncompliance.
    Matsui S
    Biometrics; 2005 Sep; 61(3):816-23. PubMed ID: 16135033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.